Andra Ap Fonden Hutchmed (China) LTD Transaction History

Andra Ap Fonden

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.63 - $15.52 $105,286 - $189,344	12,200 Added 8.56%	154,700 $1.37 Million
Q2 2022 Aug 15, 2022	BUY	$8.59 - $20.77 $1.22 Million - $2.96 Million	142,500 New	142,500 $1.8 Million
Q4 2021 Feb 15, 2022	SELL	$28.89 - $35.33 $161,784 - $197,848	-5,600 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$35.66 - $42.94 $199,695 - $240,464	5,600 New	5,600 $205,000

8.25M

3.8K

2.4K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.11B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Andra Ap Fonden with notifications on news.